Alvotech Partners with Lotus on Biosimilars to Imfinzi and Hemlibra in the US and Asia

Alvotech partners with Lotus for biosimilars to Imfinzi and Hemlibra in the US and Asia. Deal worth up to $150M plus ongoing supply revenue.